Rachid Izzar - Feb 17, 2023 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Global Product Strat.
Signature
/s/ Wendell Taylor, attorney-in-fact for Rachid Izzar
Stock symbol
BIIB
Transactions as of
Feb 17, 2023
Transactions value $
-$103,279
Form type
4
Date filed
2/22/2023, 03:57 PM
Previous filing
Feb 14, 2023
Next filing
Jul 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +767 +14.99% $0.00 5.88K Feb 17, 2023 Direct
transaction BIIB Common Stock Tax liability -$103K -371 -6.76% $278.38 5.12K Feb 17, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -767 -26.43% $0.00 2.14K Feb 17, 2023 Common Stock 767 $0.00 Direct F1
transaction BIIB Restricted Stock Unit Other $0 -681 -31.9% $0.00 1.45K Feb 17, 2023 Common Stock 681 $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).
F2 This number represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.